PTCT
PTCT
NASDAQ · Biotechnology

Ptc Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$80.96
+1.98 (+2.51%)
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Buy 16 76%
Hold 4 19%
Sell 1 5%
Price Target
Analyst Price Target -3.7% upside
Low Target $54.55
Average Target $77.98
High Target $125.35
Current Price $80.96
Current
$80.96
Target
$77.98
$54.55 $77.98 avg $125.35
Scenario Analysis
Bear Case
$54.55
-32.6%
Low target
Base Case
$77.98
-3.7%
Avg target
Bull Case
$125.35
+54.8%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$87.50
-7.5% from high
52-Week Low
$43.18
+87.5% from low
50-Day SMA
$75.08
+7.8% vs SMA
200-Day SMA
$61.55
+31.5% vs SMA
RSI (14)
25.1
Oversold
Target vs 52W High
$77.98
-10.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +12.0%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -44.6%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.4%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.1%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.5%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -31.2%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -37.5%